Top Banner
Emerging Biophotonic Technologies in the Diagnosis and Treatment of Diseases Philip Chen, MD, PhD Cognoscenti Health Institute UCF/CREOL 4/1/2005
36

Emerging Biophotonic Technologies in the Diagnosis and

Feb 03, 2022

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Emerging Biophotonic Technologies in the Diagnosis and

Emerging Biophotonic Technologies in the Diagnosis and Treatment of Diseases

Philip Chen, MD, PhDCognoscenti Health Institute

UCF/CREOL4/1/2005

Page 2: Emerging Biophotonic Technologies in the Diagnosis and

What is Biophotonics?

νν BiophotonicsBiophotonics is the science of generating and is the science of generating and harnessing light (photons) to image, detect and harnessing light (photons) to image, detect and manipulate biological materials.manipulate biological materials.

νν BiophotonicsBiophotonics is used in is used in BIOLOGYBIOLOGY to probe for to probe for molecular mechanisms, function and structure. molecular mechanisms, function and structure. It is used in It is used in MEDICINEMEDICINE to study tissue and to study tissue and blood at the macro (largeblood at the macro (large--scale) and micro scale) and micro (very small scale) organism level to detect, (very small scale) organism level to detect, diagnose and treat diseases in a way that are diagnose and treat diseases in a way that are nonnon--invasive to the body. invasive to the body.

NSF Center for NSF Center for BiophotonicsBiophotonics, Science and Technology at UCSD, Science and Technology at UCSD

Page 3: Emerging Biophotonic Technologies in the Diagnosis and

1674

Anton Van Leeuwenhoek observed bacteria, yeast and other living microorganisms under the microscope.

1665

Robert Hooke observed cells under the microscope.

Page 4: Emerging Biophotonic Technologies in the Diagnosis and

Charles A. SpencerNew York, 19th Century

“With Spencer's glasses I was able, without difficulty, to see the cross lines on the Naviculahippocampus, while with Chevalier's, by the same light, I could see them only with great difficulty.”J.W. Bailey

Prof. of Chemistry, U.S. Military AcademyThe American Journal of Science, Nov 27, 1841

Page 5: Emerging Biophotonic Technologies in the Diagnosis and

1931

Ruska and Knott invented Electron microscope. They were awarded Nobel Prize in 1986 for this invention

Page 6: Emerging Biophotonic Technologies in the Diagnosis and

1965

First production Scanning Electron Microscope, the Stereoscan was introduced by Charles Oatley

Page 7: Emerging Biophotonic Technologies in the Diagnosis and

““LightsLights”” in Medicinein Medicineνν Radiology Radiology –– XX--ray, MRI, CT Imagingray, MRI, CT Imagingνν LASIK SurgeryLASIK Surgeryνν Laser UrologyLaser Urologyνν Laser Plastic SurgeryLaser Plastic Surgeryνν Laser tissue solderingLaser tissue soldering--

””biological gluebiological glue””νν EndoscopicEndoscopic Laser OtolaryngologyLaser Otolaryngologyνν Laser DentistryLaser Dentistryνν Radiotherapy Radiotherapy –– Photons and Photons and

UltrasoundUltrasoundνν Clinical Laboratory Spectroscopy and Clinical Laboratory Spectroscopy and

MicroscopyMicroscopyνν Genomic Medicine Genomic Medicine –– Diagnosis and Diagnosis and

TreatmentTreatment

Page 8: Emerging Biophotonic Technologies in the Diagnosis and
Page 9: Emerging Biophotonic Technologies in the Diagnosis and
Page 10: Emerging Biophotonic Technologies in the Diagnosis and
Page 11: Emerging Biophotonic Technologies in the Diagnosis and

Genomic Medicine

ν Diagnoseν Predict Disease

Progressionν Treatν Monitor treatment

safety and efficacy

Page 12: Emerging Biophotonic Technologies in the Diagnosis and
Page 13: Emerging Biophotonic Technologies in the Diagnosis and

DNA-based Testing

ν Presymptomatic testing for predicting adult-onset disorders (e.g., Huntington's disease)

ν Presymptomatic testing for estimating the risk of developing adult-onset cancers and Alzheimer's disease

ν Confirmational diagnosis of a symptomatic individual (e.g., Factor V Leiden)

Page 14: Emerging Biophotonic Technologies in the Diagnosis and

DNA based testing

ν Prenatal diagnostic testing (e.g., Cystic Fibrosis)

ν Newborn screening

ν Embryos Screening (pre-implantation)

Page 15: Emerging Biophotonic Technologies in the Diagnosis and

DNA based testing

ν Carrier screening - identify unaffected individuals who carry one copy of a gene

ν Forensic/identity testing (i.e., paternity test)

Page 16: Emerging Biophotonic Technologies in the Diagnosis and

Alpha-1-antitrypsin deficiency (AAT; emphysema and liver disease) Amyotrophic lateral sclerosis (ALS; Lou Gehrig's Disease; progressive motor function loss leading to paralysis and death)

Alzheimer's disease* (APOE; late-onset variety of senile dementia) Ataxia telangiectasia (AT; progressive brain disorder resulting in loss of muscle control and cancers)

Gaucher disease (GD; enlarged liver and spleen, bone degeneration) Inherited breast and ovarian cancer* (BRCA 1 and 2; early-onset tumors of breasts and ovaries)

Hereditary nonpolyposis colon cancer* (CA; early-onset tumors of colon and sometimes other organs) Charcot-Marie-Tooth (CMT; loss of feeling in ends of limbs)

Congenital adrenal hyperplasia (CAH; hormone deficiency; ambiguous genitalia and male pseudohermaphroditism) Cystic fibrosis (CF; disease of lung and pancreas resulting in thick mucous accumulations and chronic infections)

Duchenne muscular dystrophy/Becker muscular dystrophy (DMD; severe to mild muscle wasting, deterioration, weakness) Dystonia (DYT; muscle rigidity, repetitive twisting movements)

Fanconi anemia, group C (FA; anemia, leukemia, skeletal deformities) Factor V-Leiden (FVL; blood-clotting disorder)

Fragile X syndrome (FRAX; leading cause of inherited mental retardation) Hemophilia A and B (HEMA and HEMB; bleeding disorders)

Hereditary Hemochromatosis (HFE; excess iron storage disorder) Huntington's disease (HD; usually midlife onset; progressive, lethal, degenerative neurological disease)

Myotonic dystrophy (MD; progressive muscle weakness; most common form of adult muscular dystrophy) Neurofibromatosis type 1 (NF1; multiple benign nervous system tumors that can be disfiguring; cancers)

Phenylketonuria (PKU; progressive mental retardation due to missing enzyme; correctable by diet) Adult Polycystic Kidney Disease (APKD; kidney failure and liver disease)

Prader Willi/Angelman syndromes (PW/A; decreased motor skills, cognitive impairment, early death) Sickle cell disease (SS; blood cell disorder; chronic pain and infections)

Spinocerebellar ataxia, type 1 (SCA1; involuntary muscle movements, reflex disorders, explosive speech) Spinal muscular atrophy (SMA; severe, usually lethal progressive muscle-wasting disorder in children)

Thalassemias (THAL; anemias - reduced red blood cell levels) Tay-Sachs Disease (TS; fatal neurological disease of early childhood; seizures, paralysis) [3/99]

Page 17: Emerging Biophotonic Technologies in the Diagnosis and

Pharmacogenomics(personalized medicine)

Page 18: Emerging Biophotonic Technologies in the Diagnosis and

Pharmacogenomics(personalized medicine)

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRx

RxRxRxRxRxRxRxRxRxRxRxRx

Rx

Page 19: Emerging Biophotonic Technologies in the Diagnosis and

Pharmacogenomics

ν Viral genomics ν Bacterial genomics

Page 20: Emerging Biophotonic Technologies in the Diagnosis and

Genotyping : nested RTGenotyping : nested RT--PCRPCR

RT HeatHeat

plasma HIV

Cellular HIV

HeatHeat

Page 21: Emerging Biophotonic Technologies in the Diagnosis and

Genotyping : Genotyping : ddNTddNT sequencingsequencing

Page 22: Emerging Biophotonic Technologies in the Diagnosis and

Genotyping : Genotyping : GeneChipGeneChip technologytechnology

Page 23: Emerging Biophotonic Technologies in the Diagnosis and
Page 24: Emerging Biophotonic Technologies in the Diagnosis and

K103N mutation in HIV Reverse Transcriptase - confers resistanceto all non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Page 25: Emerging Biophotonic Technologies in the Diagnosis and

Rationalized drug Rationalized drug and vaccine designand vaccine design

Page 26: Emerging Biophotonic Technologies in the Diagnosis and

Optical Probes Optical Probes --Single Molecule ImagingSingle Molecule Imaging

Page 27: Emerging Biophotonic Technologies in the Diagnosis and

Examples: In vitro Examples: In vitro Cellular Imaging to Cellular Imaging to

Target Drug TherapyTarget Drug Therapy

M3 AMLM3 AMLHer2Neu+ Breast CancerHer2Neu+ Breast Cancer

Page 28: Emerging Biophotonic Technologies in the Diagnosis and

M3 Acute M3 Acute MyelogenousMyelogenousLeukemia (AML)Leukemia (AML)

Page 29: Emerging Biophotonic Technologies in the Diagnosis and

Submit sample forFlow Cytometry(look at many markerson the cell surface)

Auer Rods! M2, M3, or M4 AML?

If M3 AML

Obtain Chromosome

Analysis (Cytogenetics)

If t(15;17) - Treat with all-trans retinoic acid (ATRA)Retinoic acid binding protein -> oncogene

Page 30: Emerging Biophotonic Technologies in the Diagnosis and

Flow Flow CytometryCytometry

Page 31: Emerging Biophotonic Technologies in the Diagnosis and

her2neuher2neu

νν OncogeneOncogene overexpressedoverexpressed in some in some breast cancers.breast cancers.

νν Can stain for overCan stain for over--expression of this expression of this protein on sections of tumor, or look protein on sections of tumor, or look for genetic alterations.for genetic alterations.

νν If positive, treat with If positive, treat with herceptinherceptin -- a a drug that targets the tumor cells.drug that targets the tumor cells.

Page 32: Emerging Biophotonic Technologies in the Diagnosis and

Flow Flow CytometryCytometry

Page 34: Emerging Biophotonic Technologies in the Diagnosis and

Fluorescent MicroscopyFluorescent Microscopy

Page 35: Emerging Biophotonic Technologies in the Diagnosis and

ConfocalConfocal MicroscopyMicroscopy

Page 36: Emerging Biophotonic Technologies in the Diagnosis and

EM/SEMEM/SEM